Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
MHT For Women With History or Risk of Cancer
Muscle Health in the Elderly
GLP-1s For OSA
Oral Corticosteroid Stewardship For Asthma – Why it is Important
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis